On February 28, BioRN Lounge hosted Martin Raditsch, Managing Partner of CARMA FUND as guest speaker.
CARMA FUND is an early-stage investment fund for advancing Life Science and Healthcare technologies. The fund started off with a First Closing in June 2022 and has €50M under management. It is based in Munich and Frankfurt am Main.
Passion for innovation and resilience make this new fund uniquely suited for young companies and projects from the life science and medical space due to an extra-long term, flexible investment modes and its close relationships with leading technology transfer offices and industry partners.
Social media posts >>
Impressions